z-logo
open-access-imgOpen Access
Comparison of cardiovascular and renal outcomes between dapagliflozin and empagliflozin in patients with type 2 diabetes without prior cardiovascular or renal disease
Author(s) -
Jayoung Lim,
InChang Hwang,
HongMi Choi,
Yeonyee E. Yoon,
Goo-Yeong Cho
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0269414
Subject(s) - dapagliflozin , empagliflozin , medicine , diabetes mellitus , renal function , type 2 diabetes , cardiology , kidney disease , endocrinology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom